The increasing field of targeted treatment relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is essential for optimizing experimental design and therapeutic efficacy. https://mixbookmark.com/story6594071/exploring-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3